Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2010
06/10/2010WO2010063566A2 Method for determining a composition of a fuel mixture
06/10/2010WO2010063522A2 Device for monitoring an operating fluid for motor vehicles and method for operating the same
06/10/2010WO2010063456A1 Test element having combined control and calibration zone
06/10/2010WO2010063392A1 Method for determining the filterability of beer
06/10/2010WO2010063359A1 Hand-held device for measuring an analyte concentration in a sample of a body liquid
06/10/2010WO2010063304A1 Test element holding system and personal diagnostic device comprising the same
06/10/2010WO2010063138A1 A monoclonal antibody specifically binding to vegf and the hybridoma secreting same and uses thereof
06/10/2010WO2010063121A1 Methods for biomarker identification and biomarker for non-small cell lung cancer
06/10/2010WO2010063116A1 Grating-based evanescent field molecular sensor using a thin silicon waveguide layer
06/10/2010WO2010048616A3 Method for screening for compounds selectively interacting with rad9
06/10/2010WO2010044689A3 Integrated screening methods for identifying modulators of mineralization, and modulators identified therefrom
06/10/2010WO2010043973A3 Biomarkers for dengue
06/10/2010WO2010037069A3 Dithienopyrrole dyes for imaging and therapy
06/10/2010WO2010033677A3 Plasmonic electricity
06/10/2010WO2010033193A3 Substrates and optical systems and methods of use thereof
06/10/2010WO2010030604A3 Methods and compositions for determining and monitoring dietary supplementation
06/10/2010WO2010029343A3 Compositions and methods for modulating skin pigmentation
06/10/2010WO2010028373A3 Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
06/10/2010WO2010028372A3 Methods and kits for the diagnosis of ryr1-related diseases
06/10/2010WO2010028072A3 Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
06/10/2010WO2010027877A3 Small molecule fluorescent sensors for detection of post-translational modifications and protein-protein interactions in bioassays
06/10/2010WO2010027785A3 Measurement of biological targets
06/10/2010WO2010022143A3 Assessing and treating breast cancer patients
06/10/2010WO2010017381A3 Methods for the diagnosis of varicella zoster virus infection
06/10/2010WO2010011281A3 Methods and compositions for the diagnosis and treatment of cancer
06/10/2010WO2010006615A3 Method and kit for assessing viable cells
06/10/2010WO2010001395A3 Detection of trinitrotoluene
06/10/2010WO2009144586A3 Method for screening compounds for their ability to increase rigidity of red blood cells infected by a protozoan parasite of the genus plasmodium, method for filtering red blood cells, and application thereof.
06/10/2010WO2009137095A3 Compositions and methods for modulating an immune response
06/10/2010WO2009111661A9 Molecular diagnosis and classification of malignant melanoma
06/10/2010WO2009026938A3 Model of information technology in pharmaceutical application (mitpa)
06/10/2010US20100146646 Method of monitoring retinopathy
06/10/2010US20100146645 Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfs1 protein as a target for identifying effective compounds against pathological anxiety
06/10/2010US20100146644 Transgenic non-human animal
06/10/2010US20100146643 Rapid in vivo model for angiogenesis
06/10/2010US20100146642 Methods and compositions relating to PBK1
06/10/2010US20100146625 Sample analyzer, sample analyzing method, and computer program product
06/10/2010US20100146300 Health monitoring system
06/10/2010US20100145733 Blood Glucose Tracking Apparatus and Methods
06/10/2010US20100145627 System with extended range of molecular sensing through integrated multi-modal data acquisition
06/10/2010US20100145626 Systems for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
06/10/2010US20100145294 Three-dimensional vertical hydration/dehydration sensor
06/10/2010US20100145229 Lancet device having capillary action
06/10/2010US20100145031 Methods for producing antibodies from plasma cells
06/10/2010US20100145027 Compositions and Methods for the Diagnosis and Treatment of Tumor
06/10/2010US20100145024 Long wavelength engineered fluorescent proteins
06/10/2010US20100144848 Dna controlled assembly of lipid membranes
06/10/2010US20100144838 Methods for Identifying Modulators of Pyrimidine Tract Binding Protein
06/10/2010US20100144837 Diagnosis and treatment of malignant neoplasms
06/10/2010US20100144822 Use of Inhibitors of the Degradation of P27, in Particular Argyrin and Derivatives Thereof, for the Treatment of Proliferative Diseases
06/10/2010US20100144805 Regulation of protein synthesis
06/10/2010US20100144793 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
06/10/2010US20100144677 Method for screening agents for the treatment of diabetes
06/10/2010US20100144646 Method of diagnosing and treating asthma
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144634 Compositions and Methods for Modulation of ADAMTS13 Activity
06/10/2010US20100144627 Methods for modulating set and uses thereof
06/10/2010US20100144623 C-Terminal Domain Truncation of mGluR1a By Calpain and Uses Thereof
06/10/2010US20100144615 Nucleotide sequence encoding a modulator of nf-kb
06/10/2010US20100144614 Altering memory by affecting staufen function
06/10/2010US20100144599 Vegf pathway blockade
06/10/2010US20100144596 An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof
06/10/2010US20100144575 Alpha-Amylase Mutants
06/10/2010US20100144540 Correlation of molecular markers with clinical outcome in gbm patients radiation treated with or without gefitinib
06/10/2010US20100144538 Genemap of the human genes associated with schizophrenia
06/10/2010US20100144061 Sequential solid phase immunoassay and system therefor
06/10/2010US20100144060 Protein detecting device
06/10/2010US20100144059 Analysis device
06/10/2010US20100144058 B-lymphocyte stimulator binding polypeptides and methods based thereon
06/10/2010US20100144057 Fluidic Force Discrimination
06/10/2010US20100144056 Particles containing detectable elemental code
06/10/2010US20100144055 Assays For Clinical Assessments of Disease-Associated Autoantibodies
06/10/2010US20100144054 Reactor plate and reaction processing method
06/10/2010US20100144050 Hydrogen peroxide detector and methods
06/10/2010US20100144049 Preconcentrator device incorporating a polymer of intrinsic microporosity
06/10/2010US20100144048 Test system for analyzing body fluids
06/10/2010US20100144047 Electrode for molecular sensing and method for molecular sensing
06/10/2010US20100144046 Cyclometalated transition metal complexes for multiplex analyte detection
06/10/2010US20100144045 Chiral selectors for separating enantiomers of a compound
06/10/2010US20100144044 Identification of phosphorylation sites in polypeptides by employment of uranyl photocleavage
06/10/2010US20100144043 Molecular fluorescence sensor for highly sensitive and selective detection of mercury
06/10/2010US20100144042 Automatic differentiation of a sample solution and a control solution
06/10/2010US20100144039 Pluripotency determining factors and uses thereof
06/10/2010US20100143958 Detection of Soluble Adiponectin Receptor Peptides and Use in Diagnostics and Therapeutics
06/10/2010US20100143956 Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
06/10/2010US20100143954 Galectin-3 Immunoassay
06/10/2010US20100143953 Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for nyha i patients
06/10/2010US20100143952 Biochip, and method for the selective identification of chlamydia trachomatis infections
06/10/2010US20100143951 Novel markers for chronic kidney disease
06/10/2010US20100143950 Binding of complement factor h to c-reactive protein
06/10/2010US20100143949 Biomarkers for colorectal cancer
06/10/2010US20100143948 Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
06/10/2010US20100143947 Reagents and methods for use in cancer diagnosis, classification and therapy
06/10/2010US20100143946 Alpha-synuclein kinase
06/10/2010US20100143945 Dna-damage-induced proteolysis
06/10/2010US20100143944 Systems and methods for rapidly changing the solution environment around sensors
06/10/2010US20100143943 Detection of dysplastic or neoplastic cells using anti-mcm2 antibodies
06/10/2010US20100143942 Method of detection
06/10/2010US20100143941 Devices and methods for detecting analytes
06/10/2010US20100143940 (3r)-hydroxyacyl-acp dehydratase enzymes used in the biosynthesis of mycolic acids and use of same for screening antibiotics
1 ... 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 ... 3937